Zhu, J., & Caflisch, A. (2016). Twenty crystal structures of bromodomain and PHD finger containing protein 1 (BRPF1)/ligand complexes reveal conserved binding motifs and rare interactions. Journal of Medicinal Chemistry, 59(11), 5555-5561. https://doi.org/10.1021/acs.jmedchem.6b00215 (Original work published)

Unzue, A., Zhao, H., Lolli, G., Dong, J., Zhu, J., Zechner, M., … Nevado, C. (2016). The "gatekeeper" residue influences the mode of binding of acetyl indoles to bromodomains. Journal of Medicinal Chemistry, 59(7), 3087-3097. https://doi.org/10.1021/acs.jmedchem.5b01757 (Original work published)

Spiliotopoulos, D., & Caflisch, A. (2016). Fragment-based in silico screening of bromodomain ligands. Drug Discovery Today. Technologies, 19, 81-90. https://doi.org/10.1016/j.ddtec.2016.06.003 (Original work published 2016)

Zhao, H., Gartenmann, L., Dong, J., Spiliotopoulos, D., & Caflisch, A. (2014). Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking. Bioorganic & Medicinal Chemistry Letters, 24(11), 2493-2496. https://doi.org/10.1016/j.bmcl.2014.04.017 (Original work published)

Steiner, S., Magno, A., Huang, D., & Caflisch, A. (2013). Does bromodomain flexibility influence histone recognition? FEBS Letters, 587(14), 2158-2163. https://doi.org/10.1016/j.febslet.2013.05.032 (Original work published)

Majeux, N., Scarsi, M., & Caflisch, A. (2001). Efficient electrostatic solvation model for protein-fragment docking. Proteins: Structure, Function, and Bioinformatics, 42(2), 256-268. https://doi.org/DOI: 10.1002/1097-0134(20010201)42:2<256::AID-PROT130>3.0.CO;2-4 (Original work published)

Scarsi, M., Majeux, N., & Caflisch, A. (1999). Hydrophobicity at the surface of proteins. Proteins: Structure, Function, and Bioinformatics, 37(4), 565-755. (Original work published)